Hemorrhagic stroke which is a shape of stroke that affects 20% of all stroke sufferers is a devastating situation for which new remedies should be developed. Current remedy techniques are pretty inadequate to reduce long time morbidity and high mortality rate, as much as 50%, related to bleeding into vital brain structures, into ventricular spaces and inside the subarachnoid space. During the remaining 10-15 years, big advances within the understanding of vital mechanisms that make a contribution to cell death and clinical deficits have been made. The maximum crucial observations revolve around a key set of primary mechanisms which might be altered in brain bleeding models, a hemorrhage cascade, along with activation of membrane metalloproteinases, oxidative strain and both inflammatory and coagulation pathways. Moreover, miles now becoming obvious that mind hemorrhage can set off the ischemic cascade in neurons, glial cells and the vascular compartment. The activation of more than one pathways allows comes the opportunity to intervene pharmacologically the usage of monotherapy or aggregate therapy. Ultimately, aggregate remedy or pleiotropic compounds with multi-target activities have to show to be greater efficacious than any single therapy alone. This article provides a comprehensive examine possible targets for small molecule intervention as well as some new techniques that bring about metabolic down-regulation or inhibition of multiple pathways simultaneously.